8 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open-Label Study of Azetukalner in Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderEnrolling by invitationPhase 32026-09-03NCT06922110
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorderEnrolling by invitationPhase 32026-09-02NCT07217860
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)Bipolar and Related Disorders, bipolar I disorder, bipolar II disorder, bipolar disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-09-02NCT07172516
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of MigraineAcute MigraineRecruitingPhase 32026-08-27NCT07674654
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migrainebrain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorderRecruitingPhase 32026-08-20NCT07645924
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-08-03NCT06775379
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 22026-08-03NCT06547489
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 22026-07-27NCT07115329